259 related articles for article (PubMed ID: 34071652)
1. Circulating RNA in Kidney Cancer: What We Know and What We Still Suppose.
Cinque A; Vago R; Trevisani F
Genes (Basel); 2021 May; 12(6):. PubMed ID: 34071652
[TBL] [Abstract][Full Text] [Related]
2. Identification of a four-microRNA panel in serum for screening renal cell carcinoma.
Chen X; Li R; Li X; Peng X; Zhang C; Liu K; Huang G; Lai Y
Pathol Res Pract; 2021 Nov; 227():153625. PubMed ID: 34628264
[TBL] [Abstract][Full Text] [Related]
3. Circulating non-coding RNAs as a diagnostic and management biomarker for breast cancer: current insights.
Hosseinalizadeh H; Mahmoodpour M; Ebrahimi A
Mol Biol Rep; 2022 Jan; 49(1):705-715. PubMed ID: 34677714
[TBL] [Abstract][Full Text] [Related]
4. Circulating large extracellular vesicles carrying CA9 in the diagnosis and prognosis of clear-cell renal cell carcinoma.
Vergori L; Martinez MC; Bigot P
Clin Transl Med; 2021 Mar; 11(3):e358. PubMed ID: 33783991
[No Abstract] [Full Text] [Related]
5. Long Non-Coding RNAs as Novel Biomarkers in the Clinical Management of Papillary Renal Cell Carcinoma Patients: A Promise or a Pledge?
Trevisani F; Floris M; Vago R; Minnei R; Cinque A
Cells; 2022 May; 11(10):. PubMed ID: 35626699
[TBL] [Abstract][Full Text] [Related]
6. The emerging role of non-coding circulating RNA as a biomarker in renal cell carcinoma.
Ellinger J; Gevensleben H; Müller SC; Dietrich D
Expert Rev Mol Diagn; 2016 Oct; 16(10):1059-1065. PubMed ID: 27649770
[TBL] [Abstract][Full Text] [Related]
7. Non-coding RNAs as biomarkers in liquid biopsies with a special emphasis on extracellular vesicles in urological malignancies.
Zeuschner P; Linxweiler J; Junker K
Expert Rev Mol Diagn; 2020 Feb; 20(2):151-167. PubMed ID: 31499007
[No Abstract] [Full Text] [Related]
8. Circulating microRNAs from the Molecular Mechanisms to Clinical Biomarkers: A Focus on the Clear Cell Renal Cell Carcinoma.
Tito C; De Falco E; Rosa P; Iaiza A; Fazi F; Petrozza V; Calogero A
Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440329
[TBL] [Abstract][Full Text] [Related]
9. Serum and urine biomarkers for human renal cell carcinoma.
Pastore AL; Palleschi G; Silvestri L; Moschese D; Ricci S; Petrozza V; Carbone A; Di Carlo A
Dis Markers; 2015; 2015():251403. PubMed ID: 25922552
[TBL] [Abstract][Full Text] [Related]
10. Expression Levels of PIWI-interacting RNA, piR-823, Are Deregulated in Tumor Tissue, Blood Serum and Urine of Patients with Renal Cell Carcinoma.
Iliev R; Fedorko M; Machackova T; Mlcochova H; Svoboda M; Pacik D; Dolezel J; Stanik M; Slaby O
Anticancer Res; 2016 Dec; 36(12):6419-6423. PubMed ID: 27919963
[TBL] [Abstract][Full Text] [Related]
11. Detection of urinary cell-free miR-210 as a potential tool of liquid biopsy for clear cell renal cell carcinoma.
Li G; Zhao A; Péoch M; Cottier M; Mottet N
Urol Oncol; 2017 May; 35(5):294-299. PubMed ID: 28089386
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma.
Zhang W; Ni M; Su Y; Wang H; Zhu S; Zhao A; Li G
Eur Urol Focus; 2018 Apr; 4(3):412-419. PubMed ID: 28753793
[TBL] [Abstract][Full Text] [Related]
13. Circulating microRNAs and extracellular vesicles as potential cancer biomarkers: a systematic review.
Matsuzaki J; Ochiya T
Int J Clin Oncol; 2017 Jun; 22(3):413-420. PubMed ID: 28243946
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH
Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382
[TBL] [Abstract][Full Text] [Related]
15. Plasma Circulating Tumor DNA and Clonal Hematopoiesis in Metastatic Renal Cell Carcinoma.
Bacon JVW; Annala M; Soleimani M; Lavoie JM; So A; Gleave ME; Fazli L; Wang G; Chi KN; Kollmannsberger CK; Wyatt AW; Nappi L
Clin Genitourin Cancer; 2020 Aug; 18(4):322-331.e2. PubMed ID: 32046920
[TBL] [Abstract][Full Text] [Related]
16. Profiling of Serum Extracellular Vesicles Reveals
Muramatsu-Maekawa Y; Kawakami K; Fujita Y; Takai M; Kato D; Nakane K; Kato T; Tsuchiya T; Koie T; Miura Y; Ito M; Mizutani K
Cancer Genomics Proteomics; 2021; 18(3):253-259. PubMed ID: 33893078
[TBL] [Abstract][Full Text] [Related]
17. Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma.
White NM; Masui O; Desouza LV; Krakovska O; Metias S; Romaschin AD; Honey RJ; Stewart R; Pace K; Lee J; Jewett MA; Bjarnason GA; Siu KW; Yousef GM
Oncotarget; 2014 Jan; 5(2):506-18. PubMed ID: 24504108
[TBL] [Abstract][Full Text] [Related]
18. Circulating adiponectin as a biomarker in renal cell carcinoma: a systematic review and meta-analysis.
Yap NY; Yap FN; Perumal K; Rajandram R
Biomarkers; 2019 Sep; 24(6):607-614. PubMed ID: 31215811
[No Abstract] [Full Text] [Related]
19. Emerging role of secreted miR-210-3p as potential biomarker for clear cell Renal Cell Carcinoma metastasis.
Petrozza V; Costantini M; Tito C; Giammusso LM; Sorrentino V; Cacciotti J; Porta N; Iaiza A; Pastore AL; Di Carlo A; Simone G; Carbone A; Gallucci M; Fazi F
Cancer Biomark; 2020; 27(2):181-188. PubMed ID: 31771042
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-30a-5p
Outeiro-Pinho G; Barros-Silva D; Aznar E; Sousa AI; Vieira-Coimbra M; Oliveira J; Gonçalves CS; Costa BM; Junker K; Henrique R; Jerónimo C
J Exp Clin Cancer Res; 2020 Jun; 39(1):98. PubMed ID: 32487203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
